Ishwa Shakir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ishwa Shakir has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Maryam Tariq
Aziz Fatimah Medical and Dental college Faisalabad Pakistan
2 shared publications - Abdullah Nadeem
Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan
1 shared publication Akash Kumar
Department of Medicine, Bilawal Medical College, Jamshoro, Pakistan
1 shared publication- Eaman Fatima
Department of Medicine, CMH Institute of Medical Sciences, Multan, Pakistan
1 shared publication - Fnu Abubakar
Department of Internal Medicine, Sanford School of Medicine, University of South Dakota, Sioux Falls, SD 57107, USA
1 shared publication - Fnu Ram
Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan
1 shared publication
Latest Publications
- Open Access
- 18 June 2026
- Published by Wolters Kluwer Health in Indian Journal of Anaesthesia
- Vol. 70 (6) , 757-763
Temporal and geographic disparities in mortality related to toxicity, adverse effects, and underdosing of anaesthetics in the United States: A CDC WONDER analysis
Background and Aims: Mortality attributed to anaesthetics and therapeutic gases is a public health concern. Recognition of this issue has increased over the years, yet research is limited. This study aimed to explore the trends and geographical differences in the United States. Methods: Deaths attributed to toxicity, adverse effects, and underdosing of anaesthetics were traced from 1999 to 2022 using the data available on the Centers for Disease Control and Prevention’s Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) website. The data were analysed according to gender, age, race, and geographic region. Results: Between 1999 and 2022, there were 10,157 anaesthesia-related deaths. The age-adjusted mortality rate (AAMR) increased from 0.1 to 0.4 from 1999 to 2022. AAMR stayed the same from 1999 to 2014, that is, 0.1 [annual percent change (APC) -0.12; 95% confidence interval (CI): -3.9 to 3.4] and increased from 2014 to 2020 to 0.4 (APC: 27.28; 95% CI: 20.8 to 49.4) and from 2020 to 2022 at 0.42 (APC: 3.54; 95% CI: -4.6 to 17.1). Among Hispanics/Latinos, mortality decreased before having a sharp increase after 2019 (AAMR 0.09, 95% CI: 0.07–0.13). Non-Hispanics (NHs) showed a similar pattern, with a notable increase seen after 2016 (Overall AAMR 0.14, 95% CI: 0.13–0.16). The northeast region exhibited an AAMR of 0.21 (0.18–0.25), 95% CI. Conclusion: Following a period of decline, mortality has increased in the United States since 2014. AAMRs were high among males, NHs, and residents of the Northeast region. The study highlights the increasing mortality along with the presence of disparities among gender, race, and region.
- 18 June 2026
- Published by Wolters Kluwer Health in Indian Journal of Anaesthesia
- Vol. 70 (6) , 757-763
Open AccessTemporal and geographic disparities in mortality related to toxicity, adverse effects, and underdosing of anaesthetics in the United States: A CDC WONDER analysis
Background and Aims: Mortality attributed to anaesthetics and therapeutic gases is a public health concern. Recognition of this issue has increased over the years, yet research is limited. This study aimed to explore the trends and geographical differences in the United States. Methods: Deaths attributed to toxicity, adverse effects, and underdosing of anaesthetics were traced from 1999 to 2022 using the data available on the Centers for Disease Control and Prevention’s Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) website. The data were analysed according to gender, age, race, and geographic region. Results: Between 1999 and 2022, there were 10,157 anaesthesia-related deaths. The age-adjusted mortality rate (AAMR) increased from 0.1 to 0.4 from 1999 to 2022. AAMR stayed the same from 1999 to 2014, that is, 0.1 [annual percent change (APC) -0.12; 95% confidence interval (CI): -3.9 to 3.4] and increased from 2014 to 2020 to 0.4 (APC: 27.28; 95% CI: 20.8 to 49.4) and from 2020 to 2022 at 0.42 (APC: 3.54; 95% CI: -4.6 to 17.1). Among Hispanics/Latinos, mortality decreased before having a sharp increase after 2019 (AAMR 0.09, 95% CI: 0.07–0.13). Non-Hispanics (NHs) showed a similar pattern, with a notable increase seen after 2016 (Overall AAMR 0.14, 95% CI: 0.13–0.16). The northeast region exhibited an AAMR of 0.21 (0.18–0.25), 95% CI. Conclusion: Following a period of decline, mortality has increased in the United States since 2014. AAMRs were high among males, NHs, and residents of the Northeast region. The study highlights the increasing mortality along with the presence of disparities among gender, race, and region.
- Open Access
- 8 November 2025
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 19 (1) , 1-11
Trends in mortality due to acute respiratory failure in the United States (1999–2020): A CDC WONDER database analysis
Background: Acute Respiratory Failure (ARF) is a serious and often life-threatening condition and has become a significant cause of morbidity and mortality over the last two decades in the United States. In this study, we analysed the temporal trends of demographic and geographical differences in Acute Respiratory Failure-related mortality among patients in the USA. Methods: Using the CDC Wide-Ranging Online Data for Epidemiologic Research (WONDER) database, this study assessed ARF mortality data from 1999 to 2020 in all age groups. Age-adjusted mortality rates (AAMRs) per 1,000,000 and annual per cent changes (APC), along with 95% CI, were calculated through joinpoint regression analysis, and data were stratified by year, age, sex, race/ethnicity, geographical regions, urbanisation, states, and place of death. Results: Between 1999 and 2020, 1,340,567 ARF-related deaths occurred among the population of all age groups. The overall AAMR increased from 55.8 in 1999 to 64.5 in 2005, followed by a sharp increase of 558.1 in 2020. Males consistently had higher AAMR than females from 1999 (AAMR males: 68.2 vs. female: 48) to 2020 (AAMR males: 682.4 vs. female: 461.2). NonHispanic (NH) American Indian or Alaska Native had the highest overall AAMR (231.1), followed by NH Black or African American (223.5), Hispanic or Latino (184.3), NH White (177), and NH Asian or Pacific Islander (133.1). AAMR also varied substantially by region, with the South having the highest AAMR (195.6), followed by the Midwest (184.5), the West (179.7) and the Northeast (152.4). Non-metropolitan areas had higher ARF-related AAMR (190.4) than metropolitan areas (179.7). Among the states, Kentucky had the highest AAMR (294.6), followed by South Carolina (284) and Indiana (276.4), while Maryland had the lowest AAMR (89.4) among the states. Most deaths (75.4%) occurred in inpatient medical facilities. Other common locations included nursing facilities (8.6%), home (7.1%), and the hospice centres (4.1%). Conclusion: ARF mortality exhibited a clear pattern: an increase gradually from 1999 to 2005, followed by a sharp increase from 2005 to 2020. The highest AAMR were observed among male sex, NH American Indian or Alaska Native ethnicity, and among patients living in the south region and non-metropolitan areas. Targeted interventions are essential to reduce ARF mortality, especially among vulnerable populations.
- 8 November 2025
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 19 (1) , 1-11
Open AccessTrends in mortality due to acute respiratory failure in the United States (1999–2020): A CDC WONDER database analysis
Background: Acute Respiratory Failure (ARF) is a serious and often life-threatening condition and has become a significant cause of morbidity and mortality over the last two decades in the United States. In this study, we analysed the temporal trends of demographic and geographical differences in Acute Respiratory Failure-related mortality among patients in the USA. Methods: Using the CDC Wide-Ranging Online Data for Epidemiologic Research (WONDER) database, this study assessed ARF mortality data from 1999 to 2020 in all age groups. Age-adjusted mortality rates (AAMRs) per 1,000,000 and annual per cent changes (APC), along with 95% CI, were calculated through joinpoint regression analysis, and data were stratified by year, age, sex, race/ethnicity, geographical regions, urbanisation, states, and place of death. Results: Between 1999 and 2020, 1,340,567 ARF-related deaths occurred among the population of all age groups. The overall AAMR increased from 55.8 in 1999 to 64.5 in 2005, followed by a sharp increase of 558.1 in 2020. Males consistently had higher AAMR than females from 1999 (AAMR males: 68.2 vs. female: 48) to 2020 (AAMR males: 682.4 vs. female: 461.2). NonHispanic (NH) American Indian or Alaska Native had the highest overall AAMR (231.1), followed by NH Black or African American (223.5), Hispanic or Latino (184.3), NH White (177), and NH Asian or Pacific Islander (133.1). AAMR also varied substantially by region, with the South having the highest AAMR (195.6), followed by the Midwest (184.5), the West (179.7) and the Northeast (152.4). Non-metropolitan areas had higher ARF-related AAMR (190.4) than metropolitan areas (179.7). Among the states, Kentucky had the highest AAMR (294.6), followed by South Carolina (284) and Indiana (276.4), while Maryland had the lowest AAMR (89.4) among the states. Most deaths (75.4%) occurred in inpatient medical facilities. Other common locations included nursing facilities (8.6%), home (7.1%), and the hospice centres (4.1%). Conclusion: ARF mortality exhibited a clear pattern: an increase gradually from 1999 to 2005, followed by a sharp increase from 2005 to 2020. The highest AAMR were observed among male sex, NH American Indian or Alaska Native ethnicity, and among patients living in the south region and non-metropolitan areas. Targeted interventions are essential to reduce ARF mortality, especially among vulnerable populations.
- 21 January 2025
- Published by Springer Nature in Wiener klinische Wochenschrift
- Vol. 137 (7-8) , 244-245
Surgical and oncological outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma
- 21 January 2025
- Published by Springer Nature in Wiener klinische Wochenschrift
- Vol. 137 (7-8) , 244-245
Surgical and oncological outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma
- 6 November 2024
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 132 (5) , 678-679
Studying Prevention of Postpartum Venous Thromboembolism With Low‐Molecular‐Weight Heparin
- 6 November 2024
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 132 (5) , 678-679
Studying Prevention of Postpartum Venous Thromboembolism With Low‐Molecular‐Weight Heparin